Hogy Medical Co.,Ltd. (TYO:3593)
Japan · Delayed Price · Currency is JPY 6,700.00
+10.00 (0.15%)
Feb 13, 2026, 3:30 PM JST
Hogy Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 222 | 2,934 | 4,075 | 6,189 | 6,286 | 6,989 |
Depreciation & Amortization | 5,442 | 5,741 | 6,607 | 3,617 | 4,115 | 4,549 |
Loss (Gain) From Sale of Assets | 429 | 534 | 169 | 464 | - | 27 |
Loss (Gain) From Sale of Investments | 1,462 | 169 | - | - | - | -1,028 |
Other Operating Activities | -3,015 | -689 | -2,269 | -1,983 | -2,090 | -2,027 |
Change in Accounts Receivable | 760 | 1,437 | -739 | -504 | 160 | -79 |
Change in Inventory | -125 | -188 | -410 | 314 | 212 | -1,050 |
Change in Accounts Payable | 181 | 721 | -602 | 802 | -337 | -408 |
Change in Other Net Operating Assets | 640 | 896 | 286 | 277 | 155 | -119 |
Operating Cash Flow | 5,653 | 11,555 | 7,117 | 9,176 | 8,501 | 6,854 |
Operating Cash Flow Growth | -50.58% | 62.36% | -22.44% | 7.94% | 24.03% | -33.42% |
Capital Expenditures | -5,459 | -5,230 | -2,686 | -1,318 | -3,048 | -7,350 |
Sale of Property, Plant & Equipment | 896 | 4 | 43 | - | 2 | 3 |
Sale (Purchase) of Intangibles | -206 | -77 | -115 | -74 | -153 | -190 |
Investment in Securities | 136 | 1,180 | -491 | -478 | -830 | 546 |
Other Investing Activities | 25 | 229 | 37 | -81 | 217 | 41 |
Investing Cash Flow | -4,633 | -3,917 | -3,262 | -1,951 | -3,812 | -6,950 |
Long-Term Debt Issued | - | 10,000 | - | - | 10,000 | - |
Long-Term Debt Repaid | - | -1,999 | -1,999 | -1,999 | -398 | -110 |
Net Debt Issued (Repaid) | -1,999 | 8,001 | -1,999 | -1,999 | 9,602 | -110 |
Issuance of Common Stock | - | - | - | - | 117 | 108 |
Repurchase of Common Stock | -1 | -11,623 | - | - | -18,773 | -453 |
Common Dividends Paid | -52 | -1,833 | -1,892 | -1,697 | -1,995 | -2,044 |
Other Financing Activities | - | - | -1 | 554 | - | -1 |
Financing Cash Flow | -3,885 | -5,455 | -3,892 | -3,142 | -11,049 | -2,500 |
Foreign Exchange Rate Adjustments | 137 | 528 | 310 | 448 | 269 | -150 |
Miscellaneous Cash Flow Adjustments | -3 | -1 | -1 | - | - | - |
Net Cash Flow | -2,731 | 2,710 | 272 | 4,531 | -6,091 | -2,746 |
Free Cash Flow | 194 | 6,325 | 4,431 | 7,858 | 5,453 | -496 |
Free Cash Flow Growth | -97.51% | 42.74% | -43.61% | 44.10% | - | - |
Free Cash Flow Margin | 0.51% | 16.16% | 11.33% | 20.16% | 14.83% | -1.36% |
Free Cash Flow Per Share | 9.00 | 282.75 | 182.59 | 323.95 | 190.91 | -16.41 |
Cash Interest Paid | 107 | 70 | 23 | 29 | 6 | 2 |
Cash Income Tax Paid | 1,847 | 737 | 2,252 | 1,958 | 2,089 | 2,025 |
Levered Free Cash Flow | - | 6,244 | 2,394 | 6,752 | 4,344 | -2,921 |
Unlevered Free Cash Flow | - | 6,288 | 2,409 | 6,770 | 4,348 | -2,919 |
Change in Working Capital | 1,456 | 2,866 | -1,465 | 889 | 190 | -1,656 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.